首页> 外文期刊>Urology >Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases.
【24h】

Primary nonurachal adenocarcinoma in the bilharzial urinary bladder: deoxyribonucleic acid flow cytometric and morphologic characterization in 93 cases.

机译:胆道膀胱原发性非尿道腺癌:脱氧核糖核酸流式细胞术和形态学表征93例。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To characterize adenocarcinomas of the urinary bladder by their DNA profiles and their proliferative properties. METHODS: Primary nonurachal adenocarcinomas, found in 93 patients with bilharzial bladder carcinomas, were studied using DNA flow cytometry. Tumor ploidy and S-phase fraction were related to tumor grade, stage, cell type, and lymph node status. RESULTS: Aneuploidy with high S-phase fractions, found in 90% of the tumors, demonstrates the high malignancy potential of these tumors, the majority of which were found to be muscle-infiltrative. There were no relationships between ploidy or S-phase fraction and tumor grade and stage. Lymph node metastases, present in 24% of the 93 patients, were found exclusively in nontetraploid aneuploid tumors with high S-phase fractions exceeding 100%. Paraffin-embedded tissues compared with fresh material gave the same information on ploidy, whereas bladder washing did not provide adequate information. CONCLUSIONS: The high aggressiveness of adenocarcinomas in the biharzial bladder is confirmed and can be explained by their proneness to develop gross chromosomal aberrations combined with high cell proliferation.
机译:目的:通过DNA谱及其增殖特性来表征膀胱腺癌。方法:使用DNA流式细胞仪研究了93例胆道膀胱癌患者中发现的原发性非尿道腺癌。肿瘤倍性和S期分数与肿瘤等级,分期,细胞类型和淋巴结状态有关。结果:在90%的肿瘤中发现具有高S期分数的非整倍性表明这些肿瘤具有很高的恶性潜能,其中大多数被发现具有肌肉浸润性。倍性或S期分数与肿瘤的分级和分期之间没有关系。 93名患者中有24%出现淋巴结转移,仅在非四倍体非整倍体肿瘤中发现,其S期分数超过100%。与新鲜材料相比,石蜡包埋的组织在倍性方面提供了相同的信息,而膀胱冲洗没有提供足够的信息。结论:腺癌在双Harharial膀胱中具有高度的侵袭性,这可以通过它们倾向于产生总染色体畸变并结合高细胞增殖来解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号